Genetic alterations and MRD refine risk assessment for <i>KMT2A</i>-rearranged B-cell precursor ALL in adults: a GRAALL studyRathana Kim, Emmanuelle Clappier, Françoise Huguet et al.|Blood|2023Cited by 29
Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B StudyNicolas Boissel, Hervé Dombret, Laurence Sanhès et al.|Blood|2022Cited by 23
Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 TrialRathana Kim, Emmanuelle Clappier, Sébastien Maury et al.|Blood|2021Cited by 9